{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:45:34Z","timestamp":1790300734887,"version":"4.1.0"},"reference-count":22,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5,1]]},"abstract":"\n BACKGROUND:<\/jats:title>\n In 2013\u20132014, an outbreak of serogroup B meningococcal disease occurred among persons linked to a New Jersey university (University A). In the absence of a licensed serogroup B meningococcal (MenB) vaccine in the United States, the Food and Drug Administration authorized use of an investigational MenB vaccine to control the outbreak. An investigation of the outbreak and response was undertaken to determine the population at risk and assess vaccination coverage.<\/jats:p>\n <\/jats:sec>\n \n METHODS:<\/jats:title>\n The epidemiologic investigation relied on compilation and review of case and population data, laboratory typing of meningococcal isolates, and unstructured interviews with university staff. Vaccination coverage data were collected during the vaccination campaign held under an expanded-access Investigational New Drug protocol.<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n Between March 25, 2013, and March 10, 2014, 9 cases of serogroup B meningococcal disease occurred in persons linked to University A. Laboratory typing results were identical for all 8 isolates available. Through May 14, 2014, 89.1% coverage with the 2-dose vaccination series was achieved in the target population. From the initiation of MenB vaccination through February 1, 2015, no additional cases of serogroup B meningococcal disease occurred in University A students. However, the ninth case occurred in March 2014 in an unvaccinated close contact of University A students.<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS:<\/jats:title>\n No serogroup B meningococcal disease cases occurred in persons who received 1 or more doses of 4CMenB vaccine, suggesting 4CMenB may have protected vaccinated individuals from disease. However, the ninth case demonstrates that carriage of serogroup B Neisseria meningitidis among vaccinated persons was not eliminated.<\/jats:p>\n <\/jats:sec>","DOI":"10.1542\/peds.2014-4015","type":"journal-article","created":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T20:32:43Z","timestamp":1430166763000},"page":"798-804","source":"Crossref","is-referenced-by-count":106,"title":["First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak"],"prefix":"10.1542","volume":"135","author":[{"given":"Lucy A.","family":"McNamara","sequence":"first","affiliation":[{"name":"Epidemic Intelligence Service Program, Division of Scientific Education and Professional Development, Center for Surveillance, Epidemiology, and Laboratory Services,"},{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice M.","family":"Shumate","sequence":"additional","affiliation":[{"name":"Epidemic Intelligence Service Program, Division of Scientific Education and Professional Development, Center for Surveillance, Epidemiology, and Laboratory Services,"},{"name":"New Jersey Department of Health, Trenton, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Johnsen","sequence":"additional","affiliation":[{"name":"Princeton University, Princeton, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"MacNeil","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Bhavsar","sequence":"additional","affiliation":[{"name":"Regulatory Affairs, Office of the Director, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda C.","family":"Cohn","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Dinitz-Sklar","sequence":"additional","affiliation":[{"name":"New Jersey Department of Health, Trenton, New Jersey;"},{"name":"Mercer County Division of Public Health, Trenton, New Jersey; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Duffy","sequence":"additional","affiliation":[{"name":"Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Finnie","sequence":"additional","affiliation":[{"name":"Princeton University, Princeton, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Garon","sequence":"additional","affiliation":[{"name":"New Jersey Department of Health, Trenton, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hary","sequence":"additional","affiliation":[{"name":"Princeton Health Department, Princeton, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Hu","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Kamiya","sequence":"additional","affiliation":[{"name":"Epidemic Intelligence Service Program, Division of Scientific Education and Professional Development, Center for Surveillance, Epidemiology, and Laboratory Services,"},{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Joo","family":"Kim","sequence":"additional","affiliation":[{"name":"Regulatory Affairs, Office of the Director, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"John","family":"Kolligian","sequence":"additional","affiliation":[{"name":"Princeton University, Princeton, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Neglia","sequence":"additional","affiliation":[{"name":"Princeton University, Princeton, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Oakley","sequence":"additional","affiliation":[{"name":"Princeton University, Princeton, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Wagner","sequence":"additional","affiliation":[{"name":"Princeton University, Princeton, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Wagner","sequence":"additional","affiliation":[{"name":"Princeton University, Princeton, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yon","family":"Yu","sequence":"additional","affiliation":[{"name":"Regulatory Affairs, Office of the Director, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Montana","sequence":"additional","affiliation":[{"name":"New Jersey Department of Health, Trenton, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Tan","sequence":"additional","affiliation":[{"name":"New Jersey Department of Health, Trenton, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Izzo","sequence":"additional","affiliation":[{"name":"Princeton University, Princeton, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Clark","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2015,5,1]]},"reference":[{"key":"2021120907105276100_B1","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"62","author":"Cohn","year":"2013","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"2021120907105276100_B2","doi-asserted-by":"crossref","first-page":"e19361","DOI":"10.1371\/journal.pone.0019361","article-title":"sodC-based real-time PCR for detection of Neisseria meningitidis.","volume":"6","author":"Dolan Thomas","year":"2011","journal-title":"PLoS ONE"},{"issue":"1","key":"2021120907105276100_B3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/JCM.42.1.320-328.2004","article-title":"Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis.","volume":"42","author":"Mothershed","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2021120907105276100_B4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/JCM.06087-11","article-title":"Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogens.","volume":"50","author":"Wang","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"6","key":"2021120907105276100_B5","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2021120907105276100_B6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1128\/JCM.39.1.75-85.2001","article-title":"Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C.","volume":"39","author":"Popovic","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"4","key":"2021120907105276100_B7","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1086\/315833","article-title":"Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998.","volume":"182","author":"Sacchi","year":"2000","journal-title":"J Infect Dis"},{"issue":"29-30","key":"2021120907105276100_B8","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1016\/j.vaccine.2011.04.092","article-title":"Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States.","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"issue":"45","key":"2021120907105276100_B9","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1073\/pnas.1013758107","article-title":"Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines.","volume":"107","author":"Donnelly","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"2021120907105276100_B10","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1016\/j.vaccine.2010.05.014","article-title":"Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.","volume":"28","author":"Giuliani","year":"2010","journal-title":"Vaccine"},{"issue":"5","key":"2021120907105276100_B11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jama.1995.03520290035026","article-title":"Serogroup C meningococcal outbreaks in the United States. An emerging threat.","volume":"273","author":"Jackson","year":"1995","journal-title":"JAMA"},{"key":"2021120907105276100_B12","first-page":"13","article-title":"Meningococcal disease and college students: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"MMWR Recomm Rep"},{"issue":"34","key":"2021120907105276100_B13","first-page":"685","article-title":"National and state vaccination coverage among adolescents aged 13-17 years\u2014United States, 2012.","volume":"62","author":"Curtis","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"2021120907105276100_B14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2021120907105276100_B15","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1128\/JCM.01653-09","article-title":"Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba.","volume":"48","author":"Climent","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"6","key":"2021120907105276100_B16","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/jama.286.6.688","article-title":"Risk factors for meningococcal disease in college students.","volume":"286","author":"Bruce","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"2021120907105276100_B17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1086\/520166","article-title":"Meningococcal disease in college students.","volume":"29","author":"Froeschle","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"20","key":"2021120907105276100_B18","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.281.20.1906","article-title":"Risk of meningococcal infection in college students.","volume":"281","author":"Harrison","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"2021120907105276100_B19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1017\/S0950268899002368","article-title":"Invasive meningococcal disease among university undergraduates: association with universities providing relatively large amounts of catered hall accommodation.","volume":"122","author":"Neal","year":"1999","journal-title":"Epidemiol Infect"},{"issue":"11","key":"2021120907105276100_B20","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.4161\/hv.25505","article-title":"Persistence of antibodies in adolescents 18-24 months after immunization with one, two, or three doses of 4CMenB meningococcal serogroup B vaccine.","volume":"9","author":"Santolaya","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"9816","key":"2021120907105276100_B21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(11)61713-3","article-title":"Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b\/3 randomised, observer-blind, placebo-controlled study.","volume":"379","author":"Santolaya","year":"2012","journal-title":"Lancet"},{"key":"2021120907105276100_B22"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/135\/5\/798\/1094356\/peds_2014-4015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/135\/5\/798\/1094356\/peds_2014-4015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T20:39:46Z","timestamp":1639082386000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/135\/5\/798\/33665\/First-Use-of-a-Serogroup-B-Meningococcal-Vaccine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,1]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,1]]},"published-print":{"date-parts":[[2015,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2014-4015","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725451366.793544026","asserted-by":"object"}]},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,1]]}}}